Related Experiment Video

Updated: Aug 11, 2026

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
08:22

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

Published on: October 27, 2020

Clinical implications of apoptosis in ischemic myocardium

Tiziano M Scarabelli1, Richard Knight, Anastasis Stephanou

  • 1Division of Cardiovascular Disease, Department of Medicine, Wayne State University, USA.

Current Problems in Cardiology
|March 1, 2006
PubMed

Insights

Apoptosis, programmed cell death, drives myocyte loss in heart disease. Targeting extrinsic factors like STAT-1, urocortins, and Bag-1, along with minocycline, may offer new cardiac therapies.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Cell Death Research

Background:

  • Apoptosis contributes to myocyte loss in cardiac pathologies like heart failure and ischemia/reperfusion injury.
  • The balance of pro- and anti-apoptotic proteins, including Bcl2 family members, regulates apoptosis.
  • Extrinsic cellular factors also influence the apoptotic response to stimuli.

Purpose of the Study:

  • To review extrinsic factors modulating apoptosis in cardiac pathologies.
  • To highlight potential therapeutic targets, including STAT-1, urocortins, and Bag-1.
  • To discuss the cytoprotective effects of minocycline.

Main Methods:

  • Review of scientific literature on apoptosis and cardiac disease.
  • Analysis of intrinsic and extrinsic apoptotic pathways.
  • Examination of therapeutic potential of identified factors.

Main Results:

  • STAT-1 acts as a pro-apoptotic agent.
  • Urocortins and Bag-1 function as anti-apoptotic factors.
  • Minocycline demonstrates significant cytoprotective effects.

Conclusions:

  • Modulating extrinsic apoptotic factors presents potential therapeutic strategies for cardiac conditions.
  • STAT-1, urocortins, and Bag-1 are key targets for intervention.
  • Minocycline offers a promising cytoprotective agent for cardiac health.

More Related Videos

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...